sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Patient Controlled Injectors Market Scope And Analysis

  • Report Code : TIPRE00015234
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Patient Controlled Injectors Market Analysis and Growth 2031

Buy Now

Patient Controlled Injectors Market Report Patient Controlled Injectors Market Size and Share Patient Controlled Injectors Market Scope and Analysis

Patient Controlled Injectors Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3.71 Billion
Market Size by 2031 US$ 12.33 Billion
Global CAGR (2023 - 2031) 12.9%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Electronic Wearable Injectors
  • Mechanical Wearable Injectors
  • Infusion Pumps
By Application
  • Cancer Treatment
  • Auto-immune Treatment
  • Blood Disorders Treatment
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Gerresheimer AG
  • Johnson and Johnson Services Inc
  • Ypsomed AG
  • Westbourne Medical Limited
  • Enable Injections
  • scPharmaceuticals Inc
  • United Therapeutics Corporation
  • BD
  • West Pharmaceutical Services Inc
  • Owen Mumford Pharmaceutical Services
    		•